0000000000421512

AUTHOR

Hannes Campo

showing 5 related works from this author

Bioengineering strategies of the uterus towards improving current investigative models and female reproductive health

2018

In this thesis, we intended to develop tissue-engineering approaches based on decellularized (DC) uterine tissues obtained from whole organs to improve several aspects within reproductive medicine. We hypothesized that that the decellularization of whole uteri from different species has not only the potential to, one day, create tissue-engineered, transplantable organs but that the DC endometrial fraction can also be processed further into thin sections, ECM hydrogels and coatings that can be used as a biocompatible tissue-specific substrate for cell and embryo culture. Moreover, we intended to corroborate if the differences in the cyclically and drastically changing endometrium are transla…

OrganoidEndometrium:CIENCIAS DE LA VIDA::Biología celular::Cultivo celular [UNESCO]UterusUNESCO::CIENCIAS DE LA VIDA::Biología celular::Cultivo celularUNESCO::CIENCIAS DE LA VIDATissue engineeringBioengineeringEmbryo culture:CIENCIAS DE LA VIDA::Biología celular::Cultivo de tejidos [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Biología celular::Cultivo de tejidos:CIENCIAS DE LA VIDA [UNESCO]
researchProduct

Improved Models of Human Endometrial Organoids Based on Hydrogels from Decellularized Endometrium

2021

Organoids are three-dimensional (3D) multicellular tissue models that mimic their corresponding in vivo tissue. Successful efforts have derived organoids from primary tissues such as intestine, liver, and pancreas. For human uterine endometrium, the recent generation of 3D structures from primary endometrial cells is inspiring new studies of this important tissue using precise preclinical models. To improve on these 3D models, we decellularized pig endometrium containing tissue-specific extracellular matrix and generated a hydrogel (EndoECM). Next, we derived three lines of human endometrial organoids and cultured them in optimal and suboptimal culture expansion media with or without EndoEC…

0301 basic medicineproliferationMedicine (miscellaneous)EndometriumArticleExtracellular matrix03 medical and health sciences0302 clinical medicineIn vivomedicineOrganoidendometriumorganoids030219 obstetrics & reproductive medicineDecellularizationChemistryECM hydrogelRCell biology030104 developmental biologymedicine.anatomical_structureSelf-healing hydrogelsImmunohistochemistryMedicinedecellularizationPancreasJournal of Personalized Medicine
researchProduct

A Natural Xenogeneic Endometrial Extracellular Matrix Hydrogel Toward Improving Current Human in vitro Models and Future in vivo Applications

2021

Decellularization techniques support the creation of biocompatible extracellular matrix hydrogels, providing tissue-specific environments for both in vitro cell culture and in vivo tissue regeneration. We obtained endometrium derived from porcine decellularized uteri to create endometrial extracellular matrix (EndoECM) hydrogels. After decellularization and detergent removal, we investigated the physicochemical features of the EndoECM, including gelation kinetics, ultrastructure, and proteomic profile. The matrisome showed conservation of structural and tissue-specific components with low amounts of immunoreactive molecules. EndoECM supported in vitro culture of human endometrial cells in t…

0301 basic medicine3D cultureHistologyStromal celllcsh:BiotechnologyBiomedical EngineeringBioengineering02 engineering and technologyExtracellular matrix03 medical and health sciencesTissue engineeringIn vivolcsh:TP248.13-248.65endometriumOriginal ResearchMatrigelDecellularizationextracellular matrix hydrogelsChemistryBioengineering and Biotechnology021001 nanoscience & nanotechnologyCell biology030104 developmental biologytissue engineeringSelf-healing hydrogelsdecellularizationStem cell0210 nano-technologyBiotechnologyFrontiers in Bioengineering and Biotechnology
researchProduct

Comparison of different sources of platelet-rich plasma as treatment option for infertility-causing endometrial pathologies

2020

Objective To study the effect of human plasma from different sources, namely, umbilical cord blood and adult blood platelet-rich plasma (PRP), on the regeneration of endometrial damage. Design Composition analysis, in vitro approaches, and a preclinical murine model using plasma to promote endometrial regeneration. Setting Hospital and university laboratories. Patient(s)/Animal(s) Adult plasma from four Asherman syndrome/endometrial atrophy patients and one fertile woman, commercial umbilical cord plasma, and uterine-damaged NOD/SCID mice model were used. Intervention(s) Endometrial stromal cells from primary culture and an endometrial stem cell line were cultured in vitro, and uterine-dama…

Adult0301 basic medicineStromal cellStem cell factorGynatresiaMice SCIDEndometriumUmbilical cordAndrologyEndometriumMice03 medical and health sciences0302 clinical medicineVon Willebrand factorMice Inbred NODmedicineAnimalsHumans030219 obstetrics & reproductive medicinebiologyPlatelet-Rich Plasmabusiness.industryRegeneration (biology)Obstetrics and GynecologyMesenchymal Stem CellsMiddle AgedFetal Blood030104 developmental biologymedicine.anatomical_structureReproductive MedicinePlatelet-rich plasmaAsherman Syndromebiology.proteinFemaleStromal CellsbusinessObstetríciaInfertility Female
researchProduct

Stem cell paracrine actions in tissue regeneration and its potential therapeutic effect in human endometrium: a retrospective study.

2020

Objective: Determining genetic and paracrine mechanisms behind endometrial regeneration in Asherman's Syndrome and Endometrial Atrophy (AS/EA) patients after autologous CD133+ bone marrow-derived stem cells (CD133+BMDSCs) transplantation. Design: Retrospective study using human endometrial biopsies and mouse models. Setting: Fundación-IVI, IIS-La Fe, Valencia, Spain. Samples: Endometrial biopsies collected before and after CD133+BMDSCs therapy, from 8 women with AS/EA (NCT02144987). And uterus from 5 mice, with only left horns receiving CD133+BMDSCs therapy. Methods: In human samples, hematoxylin and eosin (H&E) staining, RNA arrays, PCR validation and neutrophil elastase (NE) immunohistoch…

researchProduct